Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIOL BIOLASE		$0.01	$0.02 ▼ $1.94	$581K	0.67	2.58 million shs	2 shs
BJDX Bluejay Diagnostics	$1.39 +3.7%	$1.55	$1.26 ▼ $12.45	$2M	0.48	5.18 million shs	282,097 shs
BLAC Bellevue Life Sciences Acquisition	$0.50 -5.4%	$1.04	$3.01 ▼ $13.40	$2.03M	-0.08	22,626 shs	240,714 shs
LGMK LogicMark	$0.00 -5.4%	$0.00	$0.00 ▼ $7.63	$2.02M	1.5	74.75 million shs	5.43 million shs

Analysts Agree—These Gold Picks Outshine the Rest

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIOL BIOLASE	0.00%	0.00%	0.00%	-90.48%	-98.05%
BJDX Bluejay Diagnostics	+3.73%	+2.21%	-14.20%	-23.20%	-89.10%
BLAC Bellevue Life Sciences Acquisition	0.00%	-10.64%	-52.70%	-56.78%	-95.36%
LGMK LogicMark	-5.41%	-18.60%	+9.38%	-69.83%	-99.92%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BIOL BIOLASE	0.9433 of 5 stars	3.5	0.0	0.0	0.0	0.0	0.0	0.0
BJDX Bluejay Diagnostics	0.5106 of 5 stars	0.0	3.0	0.0	0.0	2.2	0.0	0.6
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LGMK LogicMark	0.5389 of 5 stars	0.0	2.0	0.0	0.0	3.3	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIOL BIOLASE	3.00	Buy	$1.20	∞ Upside
BJDX Bluejay Diagnostics	0.00	N/A	N/A	N/A
BLAC Bellevue Life Sciences Acquisition	0.00	N/A	N/A	N/A
LGMK LogicMark	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIOL BIOLASE	$48.83M	0.00	N/A	N/A	($0.07) per share	0.00
BJDX Bluejay Diagnostics	$250K	8.28	N/A	N/A	$3.54 per share	0.39
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
LGMK LogicMark	$9.88M	0.20	N/A	N/A	$148.65 per share	0.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIOL BIOLASE	-$20.63M	-$14.94	N/A	N/A	N/A	-41.65%	-1,782.73%	-55.31%	N/A
BJDX Bluejay Diagnostics	-$7.72M	-$125.15	N/A	∞	N/A	N/A	-362.07%	-299.10%	N/A
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
LGMK LogicMark	-$14.55M	-$223.50	N/A	∞	N/A	-141.96%	-124.91%	-92.05%	11/11/2025 (Estimated)

Latest BIOL, LGMK, BLAC, and BJDX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/7/2025	Q2 2025	BJDX Bluejay Diagnostics	N/A	-$1.41	N/A	-$1.41	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIOL BIOLASE	N/A	N/A	N/A	N/A	N/A
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	N/A
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	N/A	N/A	N/A
LGMK LogicMark	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIOL BIOLASE	N/A	0.71	0.36
BJDX Bluejay Diagnostics	N/A	4.56	4.56
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	N/A
LGMK LogicMark	N/A	3.73	3.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIOL BIOLASE	8.79%
BJDX Bluejay Diagnostics	18.47%
BLAC Bellevue Life Sciences Acquisition	55.30%
LGMK LogicMark	7.88%

Insider Ownership

Company	Insider Ownership
BIOL BIOLASE	0.27%
BJDX Bluejay Diagnostics	0.08%
BLAC Bellevue Life Sciences Acquisition	33.67%
LGMK LogicMark	2.17%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIOL BIOLASE	160	33.41 million	33.32 million	Not Optionable
BJDX Bluejay Diagnostics	9	1.49 million	1.49 million	Not Optionable
BLAC Bellevue Life Sciences Acquisition	N/A	4.04 million	2.68 million	Not Optionable
LGMK LogicMark	20	576.31 million	2.65 million	No Data

BIOL, LGMK, BLAC, and BJDX Headlines

Recent News About These Companies

LGMK: Device Upgrades Contribute to 2Q Revenue, Margin Improvements; Strong Balance Sheet, Sales Team Expanding

August 20 at 2:52 AM | msn.com

LogicMark Survey Reveals Women's Safety Concerns and Technology's Role in Personal Security

August 19, 2025 | quiverquant.comQ

Walking Alone at Night is the Greatest Safety Fear of Women Nationwide -- Almost Half Say Safety Concerns Limit Daily Activities LogicMark Poll Reveals

August 19, 2025 | globenewswire.com

LogicMark Reports 22% Revenue Increase in Q2 2025

August 14, 2025 | msn.com

LogicMark, Inc. (NASDAQ:LGMK) Q2 2025 Earnings Call Transcript

August 13, 2025 | insidermonkey.com

LogicMark, Inc. (LGMK) Q2 2025 Earnings Call Transcript

August 13, 2025 | seekingalpha.com

LogicMark, Inc. Reports Second Quarter 2025 Results Highlighted by 22% Sales Growth

August 12, 2025 | globenewswire.com

LogicMark, Inc. to Announce Q2 2025 Financial Results and Host Investor Call on August 12, 2025

July 29, 2025 | quiverquant.comQ

LogicMark's Holistic Approach: Leveraging Artificial Intelligence And SaaS To Protect Aging Loved Ones

June 4, 2025 | benzinga.com

LogicMark, Inc. Begins Trading on OTC Markets Following Nasdaq Delisting

June 2, 2025 | quiverquant.comQ

LogicMark, Inc. Common Stock to Commence Trading on OTC Markets as the Company Continues Advancing Growth Initiatives

June 2, 2025 | globenewswire.com

LogicMark to be delisted from Nasdaq

June 1, 2025 | uk.investing.com

LogicMark extends CEO’s contract, adjusts change control

May 22, 2025 | investing.com

LogicMark Extends CEO’s Term Amid Governance Changes

May 21, 2025 | tipranks.com

LogicMark reshuffles board, eyes tech-driven growth

April 29, 2025 | investing.com

These Seven Tiny Stocks Are Eating Up 72% Of Nasdaq Volume Today. Here Is The Fine Print.

April 29, 2025 | investors.com

LogicMark, Inc. Unveils New Board Committee Leadership Structure to Align with Strategic Goals

April 28, 2025 | globenewswire.com

LogicMark, Inc. (NASDAQ: $LGMK) Is Driving Growth Through AI-Powered Innovation!

April 24, 2025 | msn.com

LogicMark Stock Short Interest Report | NASDAQ:LGMK | Benzinga

April 19, 2025 | benzinga.com

LGMK: Potential Revenue Catalysts: GSA Approval, Medicaid Waivers, Device Upgrades

April 8, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BIOL, LGMK, BLAC, and BJDX Company Descriptions

BIOLASE NASDAQ:BIOL

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Bluejay Diagnostics NASDAQ:BJDX

$1.39 +0.05 (+3.73%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$1.40 +0.01 (+0.72%)

As of 08/22/2025 07:54 PM Eastern

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Bellevue Life Sciences Acquisition NASDAQ:BLAC

$0.50 -0.03 (-5.45%)

As of 08/20/2025

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

LogicMark NASDAQ:LGMK

$0.0035 0.00 (-5.41%)

As of 08/22/2025 03:58 PM Eastern

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company's devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one's health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time